Roche buys back shares as family group reduces voting stake in drugmaker
ZURICH (Reuters) – Roche has bought 540,000 of its own shares, the company said on Friday, as a member of its controlling family group scaled back their investment in voting…
ZURICH (Reuters) – Roche has bought 540,000 of its own shares, the company said on Friday, as a member of its controlling family group scaled back their investment in voting…
ZURICH (Reuters) – Roche has launched a new PCR test to detect a fast-spreading sub-variant of the Omicron variant of Coronavirus, the Swiss drugmaker said on Thursday. The new test…
By Julie Steenhuysen CHICAGO (Reuters) – Swiss drugmaker Roche is closing down most clinical trials of its experimental Alzheimer’s drug gantenerumab after it failed to slow advance of the mind-robbing…
ZURICH (Reuters) – Roche Holding has named Matt Sause, head of Roche Diagnostics’ North America region, to lead the group’s diagnostics business, the Swiss drugmaker said on Monday. The move…
By Natalie Grover LONDON (Reuters) – The results of a key Alzheimer’s drug trial on Wednesday have reignited decades-old hopes that targeting a particular protein helps arrest the progression of…
ZURICH – Roche has received approval from the U.S. Food and Drugs Administration for its Xofluza drug to treat influenza in children aged five years and older, the drugmaker said…